azacitidine has been researched along with Angiogenesis, Pathologic in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, J; Jiang, B; Liang, Y; Wang, B; Wang, X; Wang, Z; Xu, B; Zhang, Y; Zhou, J | 1 |
| Abboud, CN; Cashen, AF; DiPersio, JF; Gao, F; Hassan, A; Klco, JM; Procknow, E; Stockerl-Goldstein, KE; Uy, GL; Vij, R; Welch, JS; Westervelt, P | 1 |
| Anant, S; Benbrook, DM; Lightfoot, S; Mills, WK; Natarajan, G; Queimado, L; Ramachandran, I; Ramalingam, S; Reis, A; Thavathiru, E; Zuna, R | 1 |
| Chan, SH; Chen, H; Cheung, FM; Chiu, PM; Chua, D; Hyytiainen, M; Kan, R; Keski-Oja, J; Ko, JM; Kwong, DL; Lee, AW; Lung, ML; Nicholls, JM; Stanbridge, EJ; Tao, Q; Tsao, SW; Wong, VC; Zabarovsky, ER | 1 |
| Borden, EC; Fruehauf, JP; Haney, R; Jacobs, BS; Lindner, DJ; Tuthill, R; Wu, Y | 1 |
| Abildgaard, MO; Borre, M; Haldrup, C; Høyer, S; Kristensen, H; Parker, C; Strand, S; Sørensen, KD; Ulhøi, BP; Ørntoft, TF | 1 |
| Galili, N; Mehdi, M; Mumtaz, M; Qawi, H; Raza, A | 1 |
| Baylin, SB; Eguchi, S; Esteller, M; Fraga, MF; Fuks, F; Griffioen, AW; Hellebrekers, DM; Hoebers, NT; Jair, KW; van Engeland, M; Viré, E | 1 |
| Fuks, F; Griffioen, AW; Hellebrekers, DM; Herman, JG; Langenkamp, E; Melotte, V; Molema, G; Van Criekinge, W; van Engeland, M; Viré, E | 1 |
| Giles, FJ | 1 |
| List, AF | 1 |
3 review(s) available for azacitidine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Translational research in myelodysplastic syndromes.
Topics: Angiogenesis Inhibitors; Apoptosis; Azacitidine; Bone Marrow; Cell Death; Enzyme Inhibitors; Humans; Myelodysplastic Syndromes; Neovascularization, Pathologic; Thalidomide | 2004 |
Novel agents for the therapy of acute leukemia.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Azacitidine; Cysteine Endopeptidases; Cytosine; Decitabine; Dioxolanes; DNA Methylation; Humans; Leukemia; Multienzyme Complexes; Neovascularization, Pathologic; Proteasome Endopeptidase Complex | 2002 |
New approaches to the treatment of myelodysplasia.
Topics: Amifostine; Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Azacitidine; Enzyme Inhibitors; Humans; Myelodysplastic Syndromes; Neovascularization, Pathologic; Oxides; Prognosis; Proto-Oncogene Mas; Risk Factors; Severity of Illness Index; Thalidomide; Topotecan; Treatment Outcome | 2002 |
1 trial(s) available for azacitidine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a phase I study.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Azacitidine; Bone Marrow; Bone Marrow Cells; Cohort Studies; Decitabine; Dose-Response Relationship, Drug; Female; Gene Expression Profiling; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neovascularization, Pathologic; Oxides; Young Adult | 2011 |
7 other study(ies) available for azacitidine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
Topics: 3' Untranslated Regions; Azacitidine; Calcium-Binding Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Cytidine Triphosphate; DNA Methylation; EGF Family of Proteins; Endothelial Growth Factors; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; HCT116 Cells; HEK293 Cells; HT29 Cells; Humans; MicroRNAs; Neoplasm Invasiveness; Neovascularization, Pathologic; Promoter Regions, Genetic; RNA, Messenger; Vascular Endothelial Growth Factor A | 2013 |
Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Azacitidine; beta Catenin; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cervix Uteri; Decitabine; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Immunoenzyme Techniques; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Uterine Cervical Neoplasms; Wnt Proteins | 2012 |
LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma.
Topics: Azacitidine; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Decitabine; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Latent TGF-beta Binding Proteins; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neovascularization, Pathologic; Promoter Regions, Genetic; Tumor Microenvironment; Tumor Suppressor Proteins; Vascular Endothelial Growth Factor A | 2012 |
Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis.
Topics: Animals; Azacitidine; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Decitabine; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Methylation; Mice; Neovascularization, Pathologic; Promoter Regions, Genetic; Xenograft Model Antitumor Assays | 2013 |
Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer.
Topics: Aged; Aged, 80 and over; Azacitidine; Biomarkers, Tumor; CD13 Antigens; Cell Line, Tumor; Decitabine; Disease-Free Survival; DNA Methylation; Epigenesis, Genetic; Gene Silencing; Humans; Male; Middle Aged; Neovascularization, Pathologic; Promoter Regions, Genetic; Prostatectomy; Prostatic Neoplasms; Sequence Analysis, DNA | 2013 |
Angiostatic activity of DNA methyltransferase inhibitors.
Topics: Acetylation; Angiogenesis Inhibitors; Animals; Azacitidine; Cell Movement; Cytidine; DNA Modification Methylases; Endothelial Cells; Enzyme Inhibitors; Gene Expression; Histones; Humans; Hydroxamic Acids; Insulin-Like Growth Factor Binding Protein 3; Melanoma, Experimental; Mice; Mice, Mutant Strains; Neovascularization, Pathologic; Neovascularization, Physiologic; Thrombospondin 1 | 2006 |
Identification of epigenetically silenced genes in tumor endothelial cells.
Topics: Azacitidine; Caco-2 Cells; Clusterin; Colonic Neoplasms; Decitabine; DNA Methylation; DNA Modification Methylases; Endothelial Cells; Epigenesis, Genetic; Fibrillin-1; Fibrillins; Gene Expression Regulation, Neoplastic; Gene Silencing; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Microfilament Proteins; Neovascularization, Pathologic; Oxidoreductases Acting on Sulfur Group Donors; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Thioredoxins | 2007 |